Clinical trial · Interventional
Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy
Holographic Mm-wave Imaging in Radiation Oncology
NCT03789773CI-TRIAL-00063594withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Grant ended, no accrual
Summary
Brief summary (as posted)
This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanners that may be helpful in improving the efficiency and positioning of radiation oncology patients and their overall experience.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Unspecified Adult Solid Tumor | Adult Solid Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Millimeter-Wave Holographic Imaging | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Diagnostic (holographic mm-wave imaging)
- description
- Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial CT simulation.
- interventionNames
- Device: Millimeter-Wave Holographic Imaging
Primary outcomes (1)
- measure
- Qualitative assessment of holographic image quality
- timeFrame
- Up to 1 year
- description
- Qualitative assessment of image quality by study physicians according to the scoring of each image as: 1 = High Quality (A); 2= Acceptable Quality (B); 3 = Poor/Unacceptable Quality (C). Lower value (1) represents a better score than higher value (3). There are no subscales and or total scores. The quality scores of the images will be tabulated.
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who are scheduled to receive either an optical or CBCT imaging scan as part of their treatment management. * The study will be open to English and Spanish speaking participants. Exclusion Criteria: * Patients that are not scheduled for fluoroscopic or optical imaging as part of the normal course of radiotherapy.
References
Publications (0)
Data not yet available
No reference posted for this study.